November 23, 2021
The attorneys who secured a $130 million settlement for Allergan investors who sued the pharmaceutical company over allegations that it participated in a generic drug price-fixing scheme will walk away with nearly $31 million for their trouble, according to a new court filing.
July 12, 2021
Allergan has agreed to a $130 million settlement over class claims it took part in a generic-drug price-fixing scheme, investors said in seeking a New Jersey federal court's blessing for what they suggested is the first deal struck in a federal securities case related to such allegations.
January 06, 2021
The government asked a New Jersey federal court Wednesday to let it step into investors' proposed class action against Allergan over claims the pharmaceutical titan took part in a generic-drug price-fixing scheme, citing the need to ensure the integrity of related criminal affairs.
August 06, 2019
Allergan must face a proposed class action accusing the pharmaceutical company of taking part in a generic drug price-fixing scheme after a New Jersey federal judge rejected the company's dismissal bid Tuesday, finding its investors convincingly contended that Allergan violated federal antitrust and securities laws.